Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179582 · ClinicalTrials.gov registry record · NA
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00179582 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 180 participants.
The verdict
NCT00179582, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
Interventions
- DRUG VSL#3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179582
The ClinicalTrials.gov registry entry for NCT00179582 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VSL#3 is the first listed.
NCT00179582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179582 about?
NCT00179582 is a clinical study titled "Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS". To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBS
What is the current status of trial NCT00179582?
This trial is currently terminated. It is a NA study. The enrollment target is 180 participants. The study started on 2005-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00179582?
The interventions under investigation include: VSL#3 (DRUG).
Who is sponsoring clinical trial NCT00179582?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.